Intra-Cellular Therapies Statistics
Total Valuation
CCFN has a market cap or net worth of 173.21 million.
| Market Cap | 173.21M |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Friday, July 25, 2025.
| Earnings Date | Jul 25, 2025 |
| Ex-Dividend Date | May 27, 2025 |
Share Statistics
CCFN has 3.53 million shares outstanding. The number of shares has increased by 17.30% in one year.
| Current Share Class | 3.53M |
| Shares Outstanding | 3.53M |
| Shares Change (YoY) | +17.30% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 9.70% |
| Owned by Institutions (%) | n/a |
| Float | 3.19M |
Valuation Ratios
The trailing PE ratio is 8.53.
| PE Ratio | 8.53 |
| Forward PE | n/a |
| PS Ratio | 2.71 |
| PB Ratio | 0.98 |
| P/TBV Ratio | 1.22 |
| P/FCF Ratio | 10.10 |
| P/OCF Ratio | 9.38 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 3.71 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 12.21%.
| Return on Equity (ROE) | 12.21% |
| Return on Assets (ROA) | 1.27% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 270,636 |
| Profits Per Employee | 86,411 |
| Employee Count | 236 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CCFN has paid 3.71 million in taxes.
| Income Tax | 3.71M |
| Effective Tax Rate | 15.39% |
Stock Price Statistics
The stock price has increased by +44.12% in the last 52 weeks. The beta is 0.12, so CCFN's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | +44.12% |
| 50-Day Moving Average | 46.72 |
| 200-Day Moving Average | 42.44 |
| Relative Strength Index (RSI) | 66.14 |
| Average Volume (20 Days) | 227 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.13 |
Income Statement
In the last 12 months, CCFN had revenue of 63.87 million and earned 20.39 million in profits. Earnings per share was 5.75.
| Revenue | 63.87M |
| Gross Profit | 63.87M |
| Operating Income | 27.02M |
| Pretax Income | 24.10M |
| Net Income | 20.39M |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 5.75 |
Balance Sheet
The company has 40.71 million in cash and 63.57 million in debt, giving a net cash position of -22.86 million or -6.47 per share.
| Cash & Cash Equivalents | 40.71M |
| Total Debt | 63.57M |
| Net Cash | -22.86M |
| Net Cash Per Share | -6.47 |
| Equity (Book Value) | 176.28M |
| Book Value Per Share | 49.87 |
| Working Capital | -1.33B |
Cash Flow
In the last 12 months, operating cash flow was 18.46 million and capital expenditures -1.30 million, giving a free cash flow of 17.15 million.
| Operating Cash Flow | 18.46M |
| Capital Expenditures | -1.30M |
| Free Cash Flow | 17.15M |
| FCF Per Share | 4.85 |
Margins
| Gross Margin | n/a |
| Operating Margin | 42.30% |
| Pretax Margin | 37.73% |
| Profit Margin | 31.93% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 26.86% |
Dividends & Yields
This stock pays an annual dividend of 1.80, which amounts to a dividend yield of 3.67%.
| Dividend Per Share | 1.80 |
| Dividend Yield | 3.67% |
| Dividend Growth (YoY) | 31.03% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 39.59% |
| Buyback Yield | -17.30% |
| Shareholder Yield | -13.62% |
| Earnings Yield | 11.77% |
| FCF Yield | 9.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |